A Study to Evaluate the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of Repaglinide and Caffeine

Clinical trial NCT02128321 · COMPLETED

Trial details

NCT number: NCT02128321
Sponsor: Astellas Pharma Global Development, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Pharmacokinetics of Repaglinide Pharmacokinetics of Caffeine Healthy Subjects

Start date: 2014-01-01
Primary completion: 2014-02-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.